Category
    Look Into Unravel Mysteries and Abstruse Sources — Progression in Clinical Diagnosis and Treatment of NUT Carcinoma
    CHEN Shi, WANG Qian
    2024, 24(5): 257-264. DOI: 10.12019/j.issn.1671-5144.202411006
    Abstract PDF
    Disperse the Clouds, To Reveal the Clinical Application of Ifosfamide-Based Chemotherapy in Patients With Advanced NUT Carcinoma
    HAO Yue, LI Zi-ming
    2024, 24(5): 265-268. DOI: 10.12019/j.issn.1671-5144.202410029
    Abstract PDF
    A Pathway to NUT Carcinoma: Evaluation of Midline Carcinoma of Children and Young Adults With NUT Rearrangement
    WANG Ke, SONG Zheng-bo
    2024, 24(5): 269-271, 283. DOI: 10.12019/j.issn.1671-5144.202410054
    Abstract PDF
    A Rising Star, Birabresib (MK-8628) Targets Advanced Solid Tumors Including NUT Carcinoma by Inhibiting Bromodomain and Extraterminal Proteins
    CHENG Jing, LV Tang-feng
    2024, 24(5): 272-275. DOI: 10.12019/j.issn.1671-5144.202410047
    Abstract PDF
    Towards the Future: Molibresib Opens a New Chapter in the Fight Against NUT Carcinoma
    WANG Yan-hua, XU Chun-wei
    2024, 24(5): 276-279. DOI: 10.12019/j.issn.1671-5144.202410028
    Abstract PDF
    The Road Is Long and Difficult: Evaluation of the Phase Ⅰ Clinical Trial of Novel Small Molecule Pan-BET Inhibitor ODM-207 in Solid Tumor Patients
    ZHANG Qi, ZHANG Yu
    2024, 24(5): 280-283. DOI: 10.12019/j.issn.1671-5144.202410048
    Abstract PDF
    Initial Exploration of the BET Inhibitor RO6870810 in the Treatment of Solid Tumors and Lymphomas
    LUO Qiang, MENG Rui
    2024, 24(5): 284-289, 320. DOI: 10.12019/j.issn.1671-5144.202410035
    Abstract PDF
    First Light Before Dawn: Preliminary Exploration and Challenges of OTX015/MK-8628 in the Treatment of NUT Midline Carcinoma
    WEI Jing-wen, MA Xue-Lei
    2024, 24(5): 290-294. DOI: 10.12019/j.issn.1671-5144.202410052
    Abstract PDF
    Current Situation of HR-HPV Infection in Women of Different Ages and Application of TBS+DNA Dual Intelligent Diagnosis System in Cervical Cancer Screening
    YUAN Lei-lei, LAN Shi, WANG Yi-qun
    2024, 24(5): 295-303. DOI: 10.12019/j.issn.1671-5144.202404033
    Abstract PDF
    Relationship Between Dosimetric Parameters and Radiation Pneumonitis in Patients With Early Breast Cancer After Breast Conserving Surgery
    YANG Jing, DING Xia, LIU Fang, MA Mei-li, WANG Jun-hua
    2024, 24(5): 304-311. DOI: 10.12019/j.issn.1671-5144.202406033
    Abstract PDF
    Increased PLA2G2D Expression Mediates Better Prognosis in Patients With Ovarian Serous Cystadenocarcinoma
    LIU Nan-nan, CHEN Hong, SUN Wei-na, YANG Qing-qing
    2024, 24(5): 312-320. DOI: 10.12019/j.issn.1671-5144.202409006
    Abstract PDF

    Archive

    More+